血栓形成
血栓
纤维蛋白
生物材料
血小板活化
纤维蛋白原
血小板
纳米技术
材料科学
医学
免疫学
心脏病学
内科学
作者
Maud Gorbet,Claudia Sperling,Manfred F. Maitz,Christopher A. Siedlecki,Carsten Werner,Michael V. Sefton
标识
DOI:10.1016/j.actbio.2019.06.020
摘要
Following protein adsorption/activation which is the first step after the contact of material surfaces and whole blood (part 2), fibrinogen is converted to fibrin and platelets become activated and assembled in the form of a thrombus. This thrombus formation is the key feature that needs to be minimized in the creation of materials with low thrombogenicity. Further aspects of blood compatibility that are important on their own are complement and leukocyte activation which are also important drivers of thrombus formation. Hence this review summarizes the state of knowledge on all of these cascades and cells and their interactions. For each cascade or cell type, the chapter distinguishes statements which are in widespread agreement from statements where there is less of a consensus. This paper is part 3 of a series of 4 reviews discussing the problem of biomaterial associated thrombogenicity. The objective was to highlight features of broad agreement and provide commentary on those aspects of the problem that were subject to dispute. We hope that future investigators will update these reviews as new scholarship resolves the uncertainties of today.
科研通智能强力驱动
Strongly Powered by AbleSci AI